---
project:
  type: website
output-dir: docs
format:
  revealjs:
    logo: images/logos.png
    footer: "Juan David Leongómez <span style='font-size: 70%;'>PhD, MSc</span>"
    theme: simple
    center: true
    slide-number: true
    transition: fade
    background-transition: fade
editor: visual
toc: false
---

## From Theory to Practice: [Strengthening Research Integrity with *Preregistration* and *Registered Reports*]{style="font-size: 70%;"}

<br>**Juan David Leongómez** [PhD, MSc]{style="font-size: 70%;"}<br> [[jleongomez\@unbosque.edu.co](mailto:jleongomez@unbosque.edu.co)]{style="font-size: 70%;"}<br>

<img src="images/logos.png" height="100"/>

[ISHE Summer Institute 2025 · Valparaiso, Chile]{style="font-size: 70%;"}

------------------------------------------------------------------------

###  📲 Access the Slides Online {style="color:#f7766d;"} 

![](images/presentation-qr.png){width=50%}

[https://jdleongomez.github.io/preregistration-and-RRs/](https://jdleongomez.github.io/preregistration-and-RRs/){style="font-size: 70%;"}

------------------------------------------------------------------------

## Part 1: The challenges to scientific credibility

------------------------------------------------------------------------

###  {auto-animate="true"}

**Q:** What percentage of published findings in psychology are statistically significant?\

------------------------------------------------------------------------

###  {auto-animate="true"}

**Q:** What percentage of published findings in psychology are statistically significant?\
**A:** [96%]{style="font-size: 150%; color:#f7766d;"}

------------------------------------------------------------------------

###  {auto-animate="true"}

**Q:** What percentage of published findings in psychology are statistically significant?\
**A:** [96%]{style="font-size: 150%; color:#f7766d;"}

![](images/p05.png)

------------------------------------------------------------------------

###  {auto-animate="true"}

**Q:** What percentage of published findings in psychology are statistically significant?\
**A:** [96%]{style="font-size: 150%; color:#f7766d;"}

![](images/power.gif?v=1)

------------------------------------------------------------------------

###  {auto-animate="true"}

<https://shiny.jdl-svr.lat/PowerSimulate_ind_t_EN/>

<iframe src="https://shiny.jdl-svr.lat/PowerSimulate_ind_t_EN/" width="100%" height="500px" style="border: 3px solid #ccc; border-radius: 8px;">

</iframe>

------------------------------------------------------------------------

### 1.1 Can we trust the literature? {auto-animate="true"}

There are 2 options:

1.  We study effects with \>90% power and \>90% probability of being true.

------------------------------------------------------------------------

### 1.1 Can we trust the literature? {auto-animate="true"}

There are 2 options:

1.  We study effects with \>90% power and \>90% probability of being true.
2.  There is **massive publication bias**.

------------------------------------------------------------------------

### 1.1 Can we trust the literature? {auto-animate="true"}

2.  There is **massive publication bias** (in multiple disciplines).

![](images/image-4.png){width="60%"}\
[[Source](https://x.com/cremieuxrecueil/status/1772765486935056893)]{style="font-size: 50%;"}

------------------------------------------------------------------------

### 1.2 The significance filter {auto-animate="true"}

![](images/image-5.png){top="200" left="0" width="80%"}

------------------------------------------------------------------------

### 1.2 The significance filter {auto-animate="true"}

::::: columns
::: {.column width="50%"}
1.1 million z-values medical research (1976–2019) ![](images/image.png){top="200" left="0" width="400"} <br> [[van Zwet & Cator (2021)](https://doi.org/10.1111/stan.12241)]{style="font-size: 50%;"}
:::

::: {.column .fragment .fade-in width="50%"}
<br>Also PLOS ONE ![](images/image-1.png){top="200" right="50" width="400"}
:::
:::::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

1.  🧪 **P-hacking**

::: {.fragment .fade-in}
-   Trying multiple analyses to get p \< .05
-   Inflates Type I error
:::

::: {.fragment .fade-in}
2.  💡 **HARKing**
:::

::: {.fragment .fade-in}
-   Hypothesising After Results are Known
-   Misleads about test nature
:::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

2.  💡 **HARKing**

![](images/HARKing.jpeg)

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

3.  📦 **Publication Bias**

::: {.fragment .fade-in}
-   Journals prefer positive results
-   Nulls go to the file drawer
:::

::: {.fragment .fade-in}
4.  📏 **Low Statistical Power**
:::

::: {.fragment .fade-in}
-   Small samples → false negatives & inflated effects
:::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

5.  🔧 **Flexible Pipelines**

::: {.fragment .fade-in}
-   Many ways to analyse data → bias if not preplanned
:::

::: {.fragment .fade-in}
6.  🧠 **Lack of Preregistration**
:::

::: {.fragment .fade-in}
-   Can’t distinguish exploratory vs. confirmatory
:::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

7.  🧾 **Inadequate Reporting**

::: {.fragment .fade-in}
-   Missing methods, software versions, etc.
:::

::: {.fragment .fade-in}
8.  📊 **Selective Outcome Reporting**
:::

::: {.fragment .fade-in}
-   Choosing time points or measures post hoc
:::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

9.  🔄 **Data/Code not Shared**

::: {.fragment .fade-in}
-   Blocks replication & error-checking
:::

::: {.fragment .fade-in}
10. 🌐 **Cultural Incentives**
:::

::: {.fragment .fade-in}
-   Publish-or-perish culture
-   Replications & nulls undervalued
:::

------------------------------------------------------------------------

### 1.3 Threats to Scientific Replicability {auto-animate="true"}

The **four horsemen of the reproducibility apocalypse** ![](images/4horsemen.jpg)

------------------------------------------------------------------------

## Part 2: Preregistration

------------------------------------------------------------------------

### 2.1 What is preregistration? {auto-animate="true"}

**Pre-registration** is the act of specifying your research plan before conducting the study

::: {.fragment .fade-in}
![](images/cos.webp)
:::

------------------------------------------------------------------------

### 2.1 What is preregistration? {auto-animate="true"}

<https://www.cos.io/initiatives/prereg>

<iframe src="https://www.cos.io/initiatives/prereg" width="100%" height="400px" style="border: 3px solid #ccc; border-radius: 8px;">

</iframe>

------------------------------------------------------------------------

### 2.1 What is preregistration? {auto-animate="true"}

**What is preregistration?**

::: {.fragment .fade-in}
-   Define your research question and hypotheses **before** collecting data
:::

::: {.fragment .fade-in}
-   Specify your analysis plan and study design in advance
:::

::: {.fragment .fade-in}
-   Clearly link your hypotheses to your planned methods and outcomes
:::

------------------------------------------------------------------------

### 2.1 What is preregistration? {auto-animate="true"}

**Why preregister?**

::: {.fragment .fade-in}
-   Enhances **credibility** by making your intentions transparent
:::

::: {.fragment .fade-in}
-   Helps you plan better and avoid analytical drift
:::

::: {.fragment .fade-in}
-   Keeps all your design and analysis decisions in one place — even before data collection!
:::

------------------------------------------------------------------------

### 2.1 What is preregistration? {auto-animate="true"}

**Can I still explore my data?**

::: {.fragment .fade-in}
Absolutely! Preregistration doesn’t ban exploration. It just encourages **clarity** between confirmatory and exploratory analyses
:::

::: {.fragment .fade-in}
-   You can deviate from your plan. Just be upfront and explain why
:::

::: {.fragment .fade-in}
-   The goal isn’t rigidity, but **transparency**
:::

------------------------------------------------------------------------

### 2.2 Key Benefits of preregistration {auto-animate="true"}

+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Effect              | Description                          | Citation                                                                                                                                                                                                                                                                       |
+=====================+======================================+================================================================================================================================================================================================================================================================================+
| **Transparency**    | Public hypotheses & plans            | [Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT); [Marsden et al, 2022](https://doi.org/10.1111/add.15819); [Ioannidis et al, 2022](https://doi.org/10.1016/j.mbs.2022.108782); [Dewitte et al, 2021](https://doi.org/10.21428/1192f2f8.52d90db5)          |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Less Bias**       | Encourages reporting nulls           | [Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT); [Marsden et al, 2022](https://doi.org/10.1111/add.15819); [Ioannidis et al, 2022](https://doi.org/10.1016/j.mbs.2022.108782); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x)          |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Clearer Claims**  | Exploratory ≠ Confirmatory           | [Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT); [Dewitte et al, 2021](https://doi.org/10.21428/1192f2f8.52d90db5); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x)                                                                     |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Better Quality**  | Plans include power, exclusion, etc. | [Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x); [Ioannidis et al, 2022](https://doi.org/10.1016/j.mbs.2022.108782)                                                                    |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Credibility**     | Deviations are explicit              | [Ioannidis et al, 2022](https://doi.org/10.1016/j.mbs.2022.108782); [Dewitte et al, 2021](https://doi.org/10.21428/1192f2f8.52d90db5); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x); [Osborne et al, 2022](https://doi.org/10.1080/23311908.2022.2066304) |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Easier Review**   | Reviewers know the plan              | [Marsden et al, 2022](https://doi.org/10.1111/add.15819); [Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT)                                                                                                                                                 |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Better Workflow** | Forces early planning                | [Dewitte et al, 2021](https://doi.org/10.21428/1192f2f8.52d90db5); [Osborne et al, 2022](https://doi.org/10.1080/23311908.2022.2066304)                                                                                                                                        |
+---------------------+--------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

------------------------------------------------------------------------

### 2.3 Let's try a preregistration!

------------------------------------------------------------------------

<img src="images/osf-logo.png" height="200"/>

Open OSF Registries in new tab → <https://osf.io/registries>

[Note: You need to log in. If needed, create an account]{style="font-size: 50%;"}

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 1

:::::: columns
::: {.column width="65%"}
![](images/reg1.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Once you're logged into OSF, go to the **Registries** section\
-   You can browse relevant registries for inspiration\
-   To create a preregistration, click on **Add New**\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 2

:::::: columns
::: {.column width="65%"}
![](images/reg2.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   You can link your preregistration to an existing OSF project\
-   There are many templates available for different study types\
-   For this example, select the **AsPredicted.org** template\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 3

:::::: columns
::: {.column width="65%"}
![](images/reg3.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Click on **Create draft** to begin your preregistration\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 4

:::::: columns
::: {.column width="65%"}
![](images/reg4.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Fill out the following fields:
    -   **Title**\
    -   **Description**\
    -   **Contributors** (co-authors)\
    -   **License** selection\
    -   **Subject areas**\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 5

:::::: columns
::: {.column width="65%"}
![](images/reg5.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Indicate whether data collection has already begun\
-   Describe your **study plan** clearly:
    -   The more detail, the better\
    -   For **sample size**, include a justification\
        ([Lakens, 2022](https://doi.org/10.1525/collabra.33267))\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 5 (continued)

:::::: columns
::: {.column width="65%"}
![](images/justify.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Indicate whether data collection has already begun\
-   Describe your **study plan** clearly:
    -   The more detail, the better\
    -   For **sample size**, include a justification\
        ([Lakens, 2022](https://doi.org/10.1525/collabra.33267))\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 6

:::::: columns
::: {.column width="65%"}
![](images/reg6.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   Review your preregistration and correct any mistakes\
-   When ready, click **Register** to finalise\
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration! Step 7

:::::: columns
::: {.column width="65%"}
![](images/reg7.png){width="100%"}
:::

:::: {.column width="35%"}
::: {style="font-size: 60%;"}
-   You can make your preregistration **public**, or place it under an **embargo** (delayed release)
:::
::::
::::::

------------------------------------------------------------------------

### 2.3 Let's Try a Preregistration!

Each preregistration is automatically assigned a unique **URL** and a **DOI** for permanent reference.

For this workshop, I created an example:

![](images/regFin.png){width="70%"}\
👉 [View this preregistration](https://doi.org/10.17605/OSF.IO/G2QMA)

------------------------------------------------------------------------

### 2.4 Limitations & Considerations

::: {.fragment .fade-in}
-   Not a cure-all; vague preregistrations still allow bias <br>[[Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x); [Poole et al, 2024](https://doi.org/10.1177/13623613241308312)]{style="font-size: 70%;"}
:::

::: {.fragment .fade-in}
-   Concerns: bureaucracy, misuse, restriction of exploratory analysis <br>[[Toth et al, 2019](https://doi.org/10.5465/AMBPP.2019.17182ABSTRACT); [Klonsky et al, 2024](https://doi.org/10.1177/10731911241253430); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x)]{style="font-size: 70%;"}
:::

::: {.fragment .fade-in}
-   Not all research types benefit equally, but broadly beneficial <br>[[Dewitte et al, 2021](https://doi.org/10.21428/1192f2f8.52d90db5); [Ioannidis et al, 2022](https://doi.org/10.1016/j.mbs.2022.108782); [Waldron et al, 2022](https://doi.org/10.1038/s41386-022-01418-x)]{style="font-size: 70%;"}
:::

------------------------------------------------------------------------

## Part 3: Registered Reports

------------------------------------------------------------------------

### 3.1 The difference? {auto-animate="true"}

<https://www.cos.io/initiatives/registered-reports>

<iframe src="https://www.cos.io/initiatives/registered-reports" width="100%" height="500px" style="border: 3px solid #ccc; border-radius: 8px;">

</iframe>

------------------------------------------------------------------------

### 3.1 The difference? {auto-animate="true"}

-   Peer review **before** data collection
-   Accepted in principle → guaranteed publication
-   Peer-reviewed methods → stronger designs

------------------------------------------------------------------------

### 3.2 Key benefits

+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| Effect                                               | Description                                                         | Citation                                                                                                                                                                                                                                                                       |
+======================================================+=====================================================================+================================================================================================================================================================================================================================================================================+
| **Reduces Publication Bias**                         | Acceptance is based on study design, not results                    | [Chambers & Tzavella, 2021](https://doi.org/10.1038/s41562-021-01193-7); [Soderberg et al, 2021](https://doi.org/10.1038/s41562-021-01142-4); [Liu et al, 2025](https://doi.org/10.1037/amp0001503); [Chin et al, 2021](https://doi.org/10.1016/j.fsisyn.2019.10.005)          |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Methodological Rigor**                             | Early peer review enhances study design, analysis plans             | [Soderberg et al, 2021](https://doi.org/10.1038/s41562-021-01142-4); [Cook et al, 2019](https://doi.org/10.1177/0741932521996459); [2025](https://doi.org/10.1177/07319487251317533); [Lakens et al, 2024](https://doi.org/10.1080/2833373x.2024.2376046)                      |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Transparency and Reproducibility**                 | Protocols and analysis plans are pre-specified and openly available | [Chambers & Tzavella, 2021](https://doi.org/10.1038/s41562-021-01193-7); [Liu et al, 2025](https://doi.org/10.1037/amp0001503); [Nosek et al, 2014](https://doi.org/10.1027/1864-9335/A000192); [Lakens et al, 2024](https://doi.org/10.1080/2833373x.2024.2376046)            |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Reduces Questionable Practices**                   | Limits practices like p-hacking and HARKing                         | [Nosek et al, 2014](https://doi.org/10.1027/1864-9335/A000192); [Timming et al, 2021](https://doi.org/10.1111/1748-8583.12359); [Lakens et al, 2024](https://doi.org/10.1080/2833373x.2024.2376046); [Manago et al, 2023](https://doi.org/10.1007/s12108-023-09563-6)          |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Constructive Early Feedback**                      | Receive expert input on study design before data collection         | [Cook et al, 2021](https://doi.org/10.1177/0741932521996459), [2025](https://doi.org/10.1177/07319487251317533); [Cook et al, 2021](https://doi.org/10.1177/0741932521996459); [Kiyonaga et al, 2019](https://doi.org/10.1016/j.tins.2019.07.003)                              |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+
| **Promotes Acceptance of Replications/Null Results** | Encourages publication of studies regardless of outcome             | [Chambers et al, 2020](https://doi.org/10.1038/s41562-021-01193-7); [Nosek et al, 2014](https://doi.org/10.1027/1864-9335/A000192); [Lakens et al, 2024](https://doi.org/10.1080/2833373x.2024.2376046); [Henderson et al, 2022](https://doi.org/10.1371/journal.pcbi.1010571) |
+------------------------------------------------------+---------------------------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+

------------------------------------------------------------------------

### 3.3 The PCI RR model {auto-animate="true"}

![](images/pci-rr-logo.png){width="100%"}

------------------------------------------------------------------------

### 3.3 The PCI RR model {auto-animate="true"}

::::::::::: {style="font-size: 50%;"}
::: {.fragment .fade-in}
-   **Peer Community In Registered Reports (PCI RR)** is a free, non-profit platform for reviewing and recommending Registered Reports.
:::

::: {.fragment .fade-in}
-   Authors submit a Stage 1 manuscript → receive peer review → upon in-principle acceptance (IPA), they can:
:::

::: {.fragment .fade-in}
-   Publish the Stage 2 report in any of 100+ PCI RR-friendly journals
:::

::: {.fragment .fade-in}
-   Or just use the PCI RR recommendation (free, citable)
:::

::: {.fragment .fade-in}
-   Ideal for authors who want:
:::

::: {.fragment .fade-in}
-   A **journal-agnostic review process**
:::

::: {.fragment .fade-in}
-   **More control** over publication options
:::

::: {.fragment .fade-in}
-   **Transparent, open peer review**
:::
:::::::::::

------------------------------------------------------------------------

### 3.3 The PCI RR model {auto-animate="true"}

You can learn more about the submission process and browse Stage 1 and Stage 2 reports at:

🔗 [rr.peercommunityin.org](https://rr.peercommunityin.org)

<iframe src="https://rr.peercommunityin.org" width="100%" height="400px" style="border: 3px solid #ccc; border-radius: 8px;">

</iframe>

------------------------------------------------------------------------

### 3.4 Traditional vs. RRsPCI RR

::::::::::::: columns
::::::: {.column width="50%"}
**Traditional Journal**

::: {.fragment .fade-in}
-   Submit directly to journal
:::

::: {.fragment .fade-in}
-   Closed review process
:::

::: {.fragment .fade-in}
-   Journal decides on IPA and publication
:::

::: {.fragment .fade-in}
-   APCs may apply
:::
:::::::

::::::: {.column width="50%"}
**PCI RR**

::: {.fragment .fade-in}
-   Submit to platform, not journal
:::

::: {.fragment .fade-in}
-   Transparent review process
:::

::: {.fragment .fade-in}
-   Choose journal after in-principle acceptance
:::

::: {.fragment .fade-in}
-   Completely free
:::
:::::::
:::::::::::::

------------------------------------------------------------------------

### 3.5 Registered Reports: Real-World Adoption

::: {.fragment .fade-in}
-   ✅ Over **300 journals** now offer Registered Reports
:::

::: {.fragment .fade-in}
-   🧪 Used in disciplines ranging from **psychology** to **ecology**, **medicine**, and **economics**
:::

::: {.fragment .fade-in}
-   💬 Growing support from funders and institutions
:::

::: {.fragment .fade-in}
-   🌍 PCI RR offers a global, open-access alternative
:::

[Sources: cos.io, PCIRR, <a href="https://doi.org/10.1038/s41562-021-01193-7">Chambers & Tzavella, 2021</a>]{style="font-size: 60%;"}

------------------------------------------------------------------------

### 3.6 Are Registered Reports Always Appropriate?

::: {.fragment .fade-in}
-   Not ideal for **purely exploratory** or **rapid-response** studies
:::

::: {.fragment .fade-in}
-   May introduce extra planning time and peer-review delays
:::

::: {.fragment .fade-in}
-   But most **confirmatory** studies benefit from this model
:::

------------------------------------------------------------------------

### 3.7 How to Start with Registered Reports

::: {.fragment .fade-in}
1.  Pick a journal or use [PCI RR](https://rr.peercommunityin.org)
:::

::: {.fragment .fade-in}
2.  Follow the RR template (e.g., OSF, journal guidelines)
:::

::: {.fragment .fade-in}
3.  Submit your Stage 1 manuscript before collecting data
:::

::: {.fragment .fade-in}
4.  Revise based on peer review and receive IPA
:::

::: {.fragment .fade-in}
5.  Collect data → submit Stage 2 → publish with confidence!
:::

------------------------------------------------------------------------

# Questions? Discussion

Feel free to ask, critique, or share your experiences.

------------------------------------------------------------------------

## Extra (if time allows)

-   Search [OSF Registries](https://osf.io/registries?view_only=) or [PCI RR](https://rr.peercommunityin.org)
-   Discuss good vs. vague examples

------------------------------------------------------------------------

## Summary

-   Many threats to replicability are **systemic — but solvable**
-   **Preregistration** helps plan better, interpret clearly, and build credibility
-   **Registered Reports** realign incentives and reduce bias
-   Tools like OSF and PCI RR make this accessible and scalable

------------------------------------------------------------------------

## Thank you!

::::: columns
::: {.column width="50%"}
![](images/jdl_qr.png){width="60%"}
:::

::: {.column width="50%"}
<br><br><br> **Juan David Leongómez** [PhD, MSc]{style="font-size: 50%;"}<br> [[jleongomez\@unbosque.edu.co](mailto:jleongomez@unbosque.edu.co)]{style="font-size: 70%;"}<br>
:::
:::::
